Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 53:9-13, doi:10.1016/j.jacc.2008.09.054
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ceriello, A.
Right arrow Articles by Testa, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ceriello, A.
Right arrow Articles by Testa, R.

STATE-OF-THE-ART PAPER

Lowering Glucose to Prevent Adverse Cardiovascular Outcomes in a Critical Care Setting

Antonio Ceriello, MD*,*, Stuart W. Zarich, MD{dagger} and Roberto Testa, MD{ddagger}

* Centre of Excellence in Diabetes and Endocrinology, University Hospital of Coventry and Warwickshire, Warwick Medical School, University of Warwick, Coventry, United Kingdom
{dagger} Division of Cardiovascular Medicine, Bridgeport Hospital, Yale University School of Medicine, Bridgeport, Connecticut
{ddagger} Department of Gerontological Research, Diabetology Unit, INRCA, Ancona, Italy

Manuscript received April 7, 2008; revised manuscript received September 16, 2008, accepted September 23, 2008.

* Reprint requests and correspondence: Dr. Antonio Ceriello, Warwick Medical School, Clinical Science Research Institute, Clinical Science Building, University Hospital-Walsgrave Campus, Clifford Bridge Road, Coventry CV2 2DX, United Kingdom (Email: antonio.ceriello{at}warwick.ac.uk).

High admission blood glucose levels after acute myocardial infarction are common and associated with an increased risk of death in patients with or without diabetes. Hyperglycemia is associated with altered myocardial blood flow and energetics and can lead to a pro-oxidative/proinflammatory state. The use of intensive insulin treatment has shown superior benefits in the treatment of hyperglycemia versus glucose-insulin-potassium infusion, particularly in critical care settings.

Key Words: insulin • impaired glucose tolerance • diabetes • myocardial infarction

Abbreviations and Acronyms
  ACS = acute coronary syndrome
  AMI = acute myocardial infarction
  ATP = adenosine triphosphate
  CABG = coronary artery bypass grafting
  CI = confidence interval
  CV = cardiovascular
  FFA = free fatty acid
  GIK = glucose-insulin-potassium
  ICU = intensive care unit
  SPRINT = Specialized Relative Insulin and Nutrition Tables
  T2DM = type 2 diabetes mellitus




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. R. Kapoor and R. Kapoor
Strict glucose control in the cardiac intensive care unit poised for real time?
J. Am. Coll. Cardiol., July 21, 2009; 54(4): 373 - 374.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Ceriello
Reply
J. Am. Coll. Cardiol., July 21, 2009; 54(4): 374 - 374.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. J. Pepine
Insulin as a cardiovascular therapeutic: improving glycemic control in patients with coronary artery disease.
J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S1 - S2.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement